Cancer Mortality Continued to Decline Through 2022
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 16, 2025 -- Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics, 2025 report published online Jan. 16 in CA: A Cancer Journal for Clinicians.
Rebecca L. Siegel, M.P.H., from the American Cancer Society in Atlanta, and colleagues compiled the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics (through 2021 and 2022, respectively).
The authors project that 2,041,910 new cancer cases and 618,120 cancer deaths will occur in the United States in 2025. Cancer mortality continued to decline through 2022, averting almost 4.5 million deaths since 1991 due to reductions in smoking, earlier detection of some cancers, and improvements in treatment. However, concerning disparities persist, with the highest cancer mortality seen among Native Americans, including for kidney, liver, stomach, and cervical cancers, the rates of which are two to three times higher than that seen among White people. Compared with Whites, Blacks have twofold higher mortality for prostate, stomach, and uterine corpus cancers. Cancer incidence has declined in men in general, but has increased in women, narrowing the male-to-female rate ratio from 1.6 in 1992 to 1.1 in 2021. In women aged 50 to 64 years, rates have surpassed those in men (832.5 versus 830.6 per 100,000), and women younger than 50 years have a higher incidence rate than their male counterparts (82 percent compared with 51 percent in 2002).
"This progress is tempered by rising incidence in young and middle-aged women, who are often the family caregivers, and a shifting cancer burden from men to women," Siegel said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.